In partnership with the University of Southampton, Sharp Labs Europe is developing a mobile lab-on-a-chip that spits out results in minutes, potentially putting the test result waiting game to an end. Using microelectronics found in LCDs, the programmable microfluidic square splits microliters of blood -- and potentially other fluids -- into smaller droplets which it subjects to controlled chemical reactions. A single blood sample can be used for multiple tests, so there's no need to endure a barrage of pricks. Folks anxious for snappier lab results may need to sit tight, however, as it could be five to ten years before the device settles into your doctor's office. In the meantime, head past the break to get the scientific lowdown from Sharp Research Supervisor Ben Hadwen.
Continue reading Sharp Labs Europe develops portable microfluidic chip that completes blood tests in minutes
Sharp Labs Europe develops portable microfluidic chip that completes blood tests in minutes originally appeared on Engadget on Thu, 14 Jun 2012 04:41:00 EDT. Please see our terms for use of feeds.
Permalink |
Humans Invent |
Email this |
Comments
What can Theranos do to restore confidence in its company and the suddenly-in-doubt finger prick blood tests it hoped would revolutionize the industry? It's hard to say, but tonight it's trying to turn things around by announcing some executive reshu...
By the time Parkinson's disease makes itself known in humans, it's already too late for treatment. But La Trobe University in Australia has developed a test that detects a biomarker present in blood cells in folks with the disease. The school describ...
Theranos' proprietary blood-testing methods failed to meet the company's own standards as often as 87 percent of the time, according to a new report. Released by the CMS (Centers for Medicare and Medicaid Services) agency and seen in unredacted form...
The saga of startup lab Theranos continues to get increasingly complicated. The firm, known for its proprietary tests that only need a finger-prick's worth of blood for analysis, has recently faced accusations that its technology was faulty and inacc...
Controversy has swirled around Silicon Valley startup Theranos ever since the Wall Street Journal reported the company has struggled to roll out its unique blood testing technology. Since 2013 Walgreens has partnered with Theranos to use it for blo...